Genus plc (GENSF)

Market Cap	1.26B
Revenue (ttm)	845.22M
Net Income (ttm)	9.98M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	125.71
Forward PE	n/a
Dividend	0.28 (1.33%)
Ex-Dividend Date	Nov 7, 2024

Volume	300
Open	21.80
Previous Close	21.00
Day's Range	21.00 - 21.80
52-Week Range	20.51 - 28.35
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 3,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: GENSF

Financial Performance

In 2024, Genus's revenue was 668.80 million, a decrease of -3.03% compared to the previous year's 689.70 million. Earnings were 7.90 million, a decrease of -76.28%.

Financial numbers in GBP